Back
Charles River Laboratories International Vs. DaVita Industry Stock Comparison
Buy
59
CRL
Charles River Laboratories International
Last Price:
232.56
Seasonality Move:
7.05%
Buy
75
DVA
DaVita
Last Price:
137.81
Seasonality Move:
3.26%
Buy
59
Charles River Laboratories International (CRL)
is a Buy
Is Charles River Laboratories International a Buy, Sell or Hold?
- The current Charles River Laboratories International [CRL] share price is $232.82. The Score for CRL is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- CRL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
DaVita (DVA)
is a Buy
Is DaVita a Buy, Sell or Hold?
- The current DaVita [DVA] share price is $137.01. The Score for DVA is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- DVA is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CRL Stock Price Chart
What is Charles River Laboratories International's stock price today?
-
The Charles River Laboratories International share price today is $232.82
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRL is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.07 | Sell |
| Relative Strength Index (14 RSI): | 45.44 | Sell |
| Chaikin Money Flow: | 439319 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (228.05 - 239.17) | Sell |
| Bollinger Bands (100): | (220.15 - 257.23) | Sell |
DVA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.35 | Buy |
| Relative Strength Index (14 RSI): | 54.22 | Buy |
| Chaikin Money Flow: | 475979 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (130.07 - 138.23) | Buy |
| Bollinger Bands (100): | (110.44 - 136.44) | Buy |
CRL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 232.47 | Buy |
| 20-day SMA: | 231.84 | Buy |
| 50-day SMA: | 248.6 | Sell |
| 200-day SMA: | 217.93 | Buy |
| 8-day EMA: | 231.57 | Buy |
| 20-day EMA: | 234.56 | Sell |
| 50-day EMA: | 239.47 | Sell |
| 200-day EMA: | 226.76 | Buy |
DVA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 136.74 | Buy |
| 20-day SMA: | 135 | Buy |
| 50-day SMA: | 134.95 | Buy |
| 200-day SMA: | 109.52 | Buy |
| 8-day EMA: | 136.97 | Buy |
| 20-day EMA: | 135.85 | Buy |
| 50-day EMA: | 132.24 | Buy |
| 200-day EMA: | 114.53 | Buy |
Charles River Laboratories International Earnings Growth & CRL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.66 per share, a decrease next quarter of $0.11 per share, an increase this year of $0.23 per share, and an increase next year of $1.43 per share.
DaVita Earnings Growth & DVA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.66 per share, an increase next quarter of $0.13 per share, an increase this year of $1.38 per share, and an increase next year of $1.14 per share.
Charles River Laboratories International Technical Analysis
| May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
DaVita Technical Analysis
| May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||